Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), filed a Form 4 on August 26, 2026, disclosing the sale of 5,000 ordinary shares on August 25, 2026, under a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA
  • Transaction: Sale (code S) of 5,000 ordinary shares on 08/25/2026
  • Weighted average price: $8.6793 per share, with individual transactions ranging from $8.37 to $8.84
  • Shares owned after transaction: 213,387 ordinary shares held directly
  • Trading plan: Sale made pursuant to a Rule 10b5-1(c) trading plan, as noted in the filing

Philippe Menu's Share Sale at SOPHiA GENETICS: Transaction Details

According to the filing, Philippe Menu, serving as Chief Medical Officer of SOPHiA GENETICS SA, disposed of 5,000 ordinary shares on August 25, 2026. The transaction was recorded with code S, indicating a sale on the open market. The filing indicates that the transaction was made pursuant to a duly adopted trading plan under Rule 10b5-1(c).

The filing discloses that the reported price of $8.6793 is a weighted average, as the shares were sold across multiple transactions at prices ranging from $8.37 to $8.84, inclusive. According to the filing, Menu "undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."

Following the reported transaction, Menu's direct beneficial ownership stands at 213,387 ordinary shares, according to the filing. No derivative securities transactions were reported in Table II. The Form 4 was signed by Elimara Brunetto as attorney-in-fact for Philippe Menu, and filed on August 26, 2026.

What Was Disclosed

The filing reports the sale of 5,000 ordinary shares of SOPHiA GENETICS SA by Chief Medical Officer Philippe Menu on August 25, 2026, at a weighted average price of $8.6793, executed under a Rule 10b5-1(c) plan, leaving him with 213,387 shares.